| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971961A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 01/19/2000 | EP0971958A1 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971906A1 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971891A1 Thrombin inhibitors |
| 01/19/2000 | EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | EP0726899B1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 01/19/2000 | CN1048490C Cyclic derivatives, pharmacecctical compositions containg the same derivatives and their use |
| 01/19/2000 | CN1048484C A process for preparing a composition containing benzoheterocycles |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015793 Use of tagatose to enhance key blood factors |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |
| 01/18/2000 | US6015685 Ancrod proteins, their preparation and use |
| 01/18/2000 | US6015577 Treatment of strokes |
| 01/18/2000 | CA2142277C Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001704A2 Benzimidazoles, production thereof and use thereof as medicaments |
| 01/13/2000 | WO2000001666A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 01/13/2000 | WO1999055312A3 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/12/2000 | EP0970950A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970130A2 Glycosaminoglycans having high antithrombotic activity |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0969840A1 Thrombin inhibitors |
| 01/12/2000 | EP0969828A1 Butyrate prodrugs derived from lactic acid |
| 01/12/2000 | EP0969827A1 Mixture of primary fatty acids obtained from sugar cane wax |
| 01/12/2000 | EP0729362B1 TRANSDERMAL COMPOSITION OF N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-alpha-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
| 01/12/2000 | EP0693067B1 Fibrinogen receptor antagonists |
| 01/12/2000 | EP0594764B1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/12/2000 | CN1241177A Substed. 4-biphenyl-4-hydroxybutyric acid derivs. as matrix metalloprotease inhibitors |
| 01/11/2000 | US6013667 Benzenesulfonylamine compounds, process for preparing them and pharmaceutical compositions |
| 01/11/2000 | US6013627 Organic compounds |
| 01/11/2000 | US6013625 Method and composition for treating thrombosis |
| 01/11/2000 | US6013620 Contacting factor vii-containing fraction with anion exchanger, wherein factor vii is partially activated, isolating fraction containing activated factor vii, wherein fraction has factor viii inhibitor bypassing activity |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | US6013067 Methods for increasing hematopoietic cells |
| 01/07/2000 | CA2276791A1 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 01/06/2000 | WO2000000612A1 A novel human thrombopoietin mutein |
| 01/06/2000 | WO2000000465A1 Hydrazine derivatives |
| 01/06/2000 | WO1999057301A8 Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof |
| 01/06/2000 | WO1999044629A3 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 01/06/2000 | CA2335245A1 Hydrazine derivatives |
| 01/05/2000 | EP0968723A1 Healing of wounds or fibrotic disorders using at least one agent against a growth factor |
| 01/05/2000 | EP0968286A1 Growth factor receptor binding protein |
| 01/05/2000 | EP0968174A1 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock |
| 01/05/2000 | EP0967862A1 Methods and compositions for producing dried, storage-stable platelets |
| 01/05/2000 | EP0664792B1 Fibrinogen receptor antagonists |
| 01/05/2000 | EP0427765B1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
| 01/05/2000 | CN1240362A Pharmaceutical compositions for freeze drying |
| 01/04/2000 | US6011063 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 01/04/2000 | US6011050 Substituted phenethylsulfones and method of reducing TNFα levels |
| 01/04/2000 | US6011040 Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine |
| 01/04/2000 | US6010880 Inhibitors of human plasmin derived from the kunitz domains |
| 01/04/2000 | US6010844 Methods of preparing and recovering proteins |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 12/29/1999 | WO1999067244A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 12/29/1999 | WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 12/29/1999 | WO1999067207A1 Naphthalenesulfonamide derivatives and drugs containing the same |
| 12/29/1999 | WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | WO1999055339A8 Adenosine a1 receptor antagonist containing composition and method for restoring diuretic and renal function |
| 12/29/1999 | WO1999051626A3 Template associated npy y2-receptor agonists |
| 12/29/1999 | EP0966965A1 Methods for reducing levels of homocysteine and C-reactive protein |
| 12/29/1999 | EP0966536A1 Factor x analogues with a modified protease cleavage site |
| 12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
| 12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
| 12/29/1999 | EP0966454A1 Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 12/29/1999 | EP0966283A2 Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 12/29/1999 | EP0966209A1 Cooked cereal ingredient-containing products fortified with edta/iron compositions and methods for use |
| 12/29/1999 | EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof |
| 12/29/1999 | CN1239959A Subsitutted 2(2,6-dioxopiperidin-3-yl) phthalimides and -1-xoisoindolines and method of reducing TNF-alpha levels |
| 12/29/1999 | CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors |
| 12/29/1999 | CN1239944A New pentaerythritol derivatives, their production, and use and intermdiates for their synthesis |
| 12/29/1999 | CN1047778C Pyrimido [5,4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them |
| 12/29/1999 | CN1047775C N-piperidino 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl pyrazole-3-formyl amide, its preparation and drug composition |
| 12/29/1999 | CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion |
| 12/29/1999 | CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 12/29/1999 | CA2335193A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 12/28/1999 | US6008367 Intermediate for synthesis of anticoagulant agents |
| 12/28/1999 | US6008351 Peptide aldehyde compounds having uracil or pyrimidin-4-one groups as part of the peptide backbone; potent inhibitors of thrombin |
| 12/28/1999 | US6008336 Compacted nucleic acids and their delivery to cells |
| 12/28/1999 | US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia |
| 12/28/1999 | US6008214 Inhibiting platelet aggregation and bone resorption, treating stroke, transient ischemia attacks, or myocardial infarction, treating osteoporosis |
| 12/28/1999 | US6008199 Continuously infusing an activated protein c for about 24 to 144 hours |
| 12/28/1999 | US6008198 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same |
| 12/28/1999 | US6007819 Administering to mammal an antigen and a dipeptide-derivative to induce immunoglobulin g immune response; vaccines |
| 12/28/1999 | CA1340866C Human c3b/c4b receptor (cr1) |
| 12/23/1999 | WO1999066031A2 Pharmaceutical factor vii preparation |
| 12/23/1999 | WO1999065934A1 Antithrombotic compounds |